ARTICLE | Company News
Pieris, Daiichi Sankyo deal
April 18, 2011 7:00 AM UTC
Pieris will use its Anticalin scaffold technology to discover Anticalin candidates against two undisclosed targets selected by Daiichi. Anticalins are engineered proteins with antibody-like binding pr...